{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T18:50:18Z","timestamp":1740163818485,"version":"3.37.3"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,21]],"date-time":"2021-06-21T00:00:00Z","timestamp":1624233600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,21]],"date-time":"2021-06-21T00:00:00Z","timestamp":1624233600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Kaohsiung Medical University Research Center Grant","award":["KMU-TC108A01","KMU-TC108A01"],"award-info":[{"award-number":["KMU-TC108A01","KMU-TC108A01"]}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST109-2314-B-037-066"],"award-info":[{"award-number":["MOST109-2314-B-037-066"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004737","name":"National Health Research Institutes, Taiwan","doi-asserted-by":"crossref","award":["NHRI-EX107-10703PI"],"award-info":[{"award-number":["NHRI-EX107-10703PI"]}],"id":[{"id":"10.13039\/501100004737","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Non-communicable diseases are increasing faster in HIV\/AIDS patients than in the general population. We studied the association between hypertension and other possible confounding factors on viral load and CD4-cell counts in hypertensive and non-hypertensive HIV\/AIDS patients receiving antiretroviral therapy (ART) at a large hospital in Eswatini over a 4-year period. We performed a retrospective longitudinal review of the medical records of 560 ART patients divided into non-hypertension and hypertension groups (n\u2009=\u2009325 and n\u2009=\u2009235) from July 27 to September 8, 2018. Generalized Estimated Equation was used to analyze the longitudinal data. Hypertensive patients were more likely to have improved CD4-cell counts than non-hypertensive patients (OR\u2009=\u20091.83, [1.37\u20132.44]). ART patients with hypertension were more likely to have detectable viral loads, though not significant (OR\u2009=\u20091.37 [0.77\u20132.43]). In non-hypertensive patients, second line ART was significantly associated with viral load (OR\u2009=\u20098.61 [2.93\u201325.34]) and adverse side effects (OR\u2009=\u20093.50 [1.06\u201311.54]), while isoniazid preventive therapy was significantly associated with CD4-cell counts (OR\u2009=\u20091.68 [1.16\u20132.45]). In hypertensive patients, factors associated with viral load were WHO\u00a0HIV stage (OR\u2009=\u20092.84 [1.03\u20137.85]) and adherence (OR\u2009=\u20098.08 [1.33\u201349.04]). In both groups, CD4-cell counts significantly and steadily increased over time (p-value\u2009&lt;\u20090.001). Results show a significant association between hypertension and CD4 cell counts but not viral load. In ART patients with and without hypertension, the factors associated with prognostic markers were different. More attention may need to be paid to ART patients with well controlled HIV status to monitoring and controlling of hypertension status.<\/jats:p>","DOI":"10.1038\/s41598-021-92185-0","type":"journal-article","created":{"date-parts":[[2021,6,21]],"date-time":"2021-06-21T10:03:10Z","timestamp":1624269790000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Factors associated with prognostic or treatment outcomes in HIV\/AIDS patients with and without hypertension in Eswatini"],"prefix":"10.1038","volume":"11","author":[{"given":"Sabelo Bonginkosi","family":"Dlamini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans-Uwe","family":"Dahms","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Tsang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,6,21]]},"reference":[{"key":"92185_CR1","unstructured":"World Health Organization. Non-communicable diseases https:\/\/who.int\/news-room\/fact-sheet\/detail\/noncommunicable-diseases (2021)."},{"key":"92185_CR2","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1016\/S0140-6736(12)61766-8","volume":"380","author":"SS Lim","year":"2012","unstructured":"Lim, S. S. et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990\u20132010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet 380, 2224\u20132260. https:\/\/doi.org\/10.1016\/S0140-6736(12)61766-8 (2012).","journal-title":"Lancet"},{"key":"92185_CR3","doi-asserted-by":"publisher","first-page":"S40","DOI":"10.1097\/QAI.0000000000000257","volume":"67","author":"GS Bloomfield","year":"2014","unstructured":"Bloomfield, G. S. et al. HIV and non-communicable cardiovascular and pulmonary diseases in low-and middle-income countries in the ART era: What we know and best directions for future research. J. Acquir. Immune Defic. Syndr. (1999) 67, S40 (2014).","journal-title":"J. Acquir. Immune Defic. Syndr. (1999)"},{"key":"92185_CR4","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1097\/01.aids.0000222074.45372.00","volume":"20","author":"HM Crane","year":"2006","unstructured":"Crane, H. M., Van Rompaey, S. E. & Kitahata, M. M. Antiretroviral medications associated with elevated blood pressure among patients receiving highly active antiretroviral therapy. AIDS 20, 1019\u20131026 (2006).","journal-title":"AIDS"},{"key":"92185_CR5","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1590\/0034-7167-2016-0416","volume":"70","author":"MAC Lima","year":"2017","unstructured":"Lima, M. A. C. et al. Systemic arterial hypertension in people living with HIV\/AIDS: Integrative review. Rev. Bras. Enferm. 70, 1309\u20131317. https:\/\/doi.org\/10.1590\/0034-7167-2016-0416 (2017).","journal-title":"Rev. Bras. Enferm."},{"key":"92185_CR6","unstructured":"Centers for Disease Control and Prevention. High blood pressure. Know your risk for high blood pressure, https:\/\/cdc.gov\/bloodpressure\/risk_factors.htm (2020)."},{"key":"92185_CR7","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/s0140-6736(19)32008-2","volume":"395","author":"S Yusuf","year":"2020","unstructured":"Yusuf, S. et al. Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): A prospective cohort study. Lancet 395, 795\u2013808. https:\/\/doi.org\/10.1016\/s0140-6736(19)32008-2 (2020).","journal-title":"Lancet"},{"key":"92185_CR8","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1016\/0002-9149(89)90014-3","volume":"63","author":"SE Lipshultz","year":"1989","unstructured":"Lipshultz, S. E. et al. Cardiovascular manifestations of human immunodeficiency virus infection in infants and children. Am. J. Cardiol. 63, 1489\u20131497 (1989).","journal-title":"Am. J. Cardiol."},{"key":"92185_CR9","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1007\/s11906-000-0031-1","volume":"2","author":"S Aoun","year":"2000","unstructured":"Aoun, S. & Ramos, E. Hypertension in the HIV-infected patient. Curr. Hypertens. Rep 2, 478\u2013481. https:\/\/doi.org\/10.1007\/s11906-000-0031-1 (2000).","journal-title":"Curr. Hypertens. Rep"},{"key":"92185_CR10","unstructured":"Avert. Global HIV and AIDS Statistics, https:\/\/avert.org\/global-hiv-and-aids-statistics\/ (2020)."},{"key":"92185_CR11","unstructured":"Joint United Nations Programme on HIV\/AIDS. Fact sheet: World AIDS Day 2019\u2014global HIV statistics (2019)."},{"key":"92185_CR12","unstructured":"Eswatini Ministry of Health. In Ministry of Health Swaziland: Mbabane, Swaziland (2017)."},{"key":"92185_CR13","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1080\/09540120902862576","volume":"21","author":"LN Makoae","year":"2009","unstructured":"Makoae, L. N. et al. The impact of taking or not taking ARVs on HIV stigma as reported by persons living with HIV infection in five African countries. AIDS Care 21, 1357\u20131362 (2009).","journal-title":"AIDS Care"},{"key":"92185_CR14","doi-asserted-by":"publisher","first-page":"S65","DOI":"10.1097\/QAD.0b013e328355ab72","volume":"26","author":"LR Hirschhorn","year":"2012","unstructured":"Hirschhorn, L. R., Kaaya, S. F., Garrity, P. S., Chopyak, E. & Fawzi, M. C. Cancer and the \u2018other\u2019 noncommunicable chronic diseases in older people living with HIV\/AIDS in resource-limited settings: A challenge to success. AIDS 26, S65\u2013S75 (2012).","journal-title":"AIDS"},{"key":"92185_CR15","doi-asserted-by":"publisher","first-page":"e1003020","DOI":"10.1371\/journal.pmed.1003020","volume":"16","author":"EH Geng","year":"2019","unstructured":"Geng, E. H., Holmes, C. B., Moshabela, M., Sikazwe, I. & Petersen, M. L. Personalized public health: An implementation research agenda for the HIV response and beyond. PLoS Med. 16, e1003020. https:\/\/doi.org\/10.1371\/journal.pmed.1003020 (2019).","journal-title":"PLoS Med."},{"key":"92185_CR16","first-page":"63","volume":"5","author":"DA Watkins","year":"2016","unstructured":"Watkins, D. A. et al. Delivery of health care for cardiovascular and metabolic diseases among people living with HIV\/AIDS in African countries: A systematic review protocol. Syst. Control Found. Appl. 5, 63 (2016).","journal-title":"Syst. Control Found. Appl."},{"key":"92185_CR17","volume-title":"Global report: UNAIDS Report on the Global AIDS Epidemic 2013","author":"Joint United Nations Programme on HIV\/AIDS","year":"2013","unstructured":"Joint United Nations Programme on HIV\/AIDS. Global report: UNAIDS Report on the Global AIDS Epidemic 2013 (Joint United Nations Programme on HIV, 2013)."},{"key":"92185_CR18","unstructured":"Marquez, P. V. & Farrington, J. L. The Challenge of Non-communicable Diseases and Road Traffic Injuries in Sub-saharan Africa: An Overview (2013)."},{"key":"92185_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12961-019-0428-z","volume":"17","author":"FC Mukumbang","year":"2019","unstructured":"Mukumbang, F. C., Orth, Z. & van Wyk, B. What do the implementation outcome variables tell us about the scaling-up of the antiretroviral treatment adherence clubs in South Africa? A document review. Health Res. Policy Syst. 17, 1\u201312 (2019).","journal-title":"Health Res. Policy Syst."},{"key":"92185_CR20","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1136\/bmj.325.7370.954","volume":"325","author":"MM Kitahata","year":"2002","unstructured":"Kitahata, M. M., Tegger, M. K., Wagner, E. H. & Holmes, K. K. Comprehensive health care for people infected with HIV in developing countries. BMJ 325, 954\u2013957 (2002).","journal-title":"BMJ"},{"key":"92185_CR21","unstructured":"US Department of Health and Human Services. Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents Living with HIV (2018)."},{"key":"92185_CR22","unstructured":"World Health Organization. WHO guidelines on the use of CD4, Viral load and early infant diagnosis (EID) tests for initiation and monitoring of ART."},{"key":"92185_CR23","unstructured":"Panel on Antiretroviral Guidelines for Adults Adolescents. Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents Living with HIV (Department of Health and Human Services, 2018)."},{"key":"92185_CR24","unstructured":"Joint United Nations Programme on HIV\/AIDS. Fast-track: ending the AIDS epidemic by 2030 (2014)."},{"key":"92185_CR25","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1097\/QAD.0000000000001671","volume":"32","author":"N Ford","year":"2018","unstructured":"Ford, N. et al. Benefits and risks of rapid initiation of antiretroviral therapy. AIDS 32, 17 (2018).","journal-title":"AIDS"},{"key":"92185_CR26","doi-asserted-by":"publisher","first-page":"401","DOI":"10.7326\/0003-4819-133-6-200009190-00007","volume":"133","author":"S Grabar","year":"2000","unstructured":"Grabar, S. et al. Clinical outcome of patients with HIV-1 infection according to immunologic and virologic response after 6 months of highly active antiretroviral therapy. Ann. Intern. Med. 133, 401\u2013410 (2000).","journal-title":"Ann. Intern. Med."},{"key":"92185_CR27","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1161\/01.CIR.94.3.483","volume":"94","author":"L Chasan-Taber","year":"1996","unstructured":"Chasan-Taber, L. et al. Prospective study of oral contraceptives and hypertension among women in the United States. Circulation 94, 483\u2013489 (1996).","journal-title":"Circulation"},{"key":"92185_CR28","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/sj.jhh.1001841","volume":"19","author":"J Lubianca","year":"2005","unstructured":"Lubianca, J., Moreira, L., Gus, M. & Fuchs, F. Stopping oral contraceptives: An effective blood pressure-lowering intervention in women with hypertension. J. Hum. Hypertens. 19, 451\u2013455 (2005).","journal-title":"J. Hum. Hypertens."},{"key":"92185_CR29","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1097\/QAD.0b013e32835bb672","volume":"27","author":"SJ Phillips","year":"2013","unstructured":"Phillips, S. J., Curtis, K. M. & Polis, C. B. Effect of hormonal contraceptive methods on HIV disease progression: A systematic review. AIDS 27, 787\u2013794 (2013).","journal-title":"AIDS"},{"key":"92185_CR30","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1097\/QAD.0b013e32832cbca8","volume":"23","author":"EM Stringer","year":"2009","unstructured":"Stringer, E. M. et al. HIV disease progression by hormonal contraceptive method: Secondary analysis of a randomized trial. AIDS 23, 1377 (2009).","journal-title":"AIDS"},{"key":"92185_CR31","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1111\/j.1478-3231.2011.02749.x","volume":"32","author":"HN Park","year":"2012","unstructured":"Park, H. N. et al. Upper normal threshold of serum alanine aminotransferase in identifying individuals at risk for chronic liver disease. Liver Int. 32, 937\u2013944 (2012).","journal-title":"Liver Int."},{"key":"92185_CR32","unstructured":"McAuley, D. Laboratory Values (Global RPH, 2017)."},{"key":"92185_CR33","unstructured":"Lewin, J. & Marcin, J. What is the normal range for a creatinine blood test? Medical News Today https:\/\/www.medicalnewstoday.com\/articles\/322380.php (2018)."},{"key":"92185_CR34","unstructured":"NAM\/aidsmap. Viral Load https:\/\/www.aidsmap.com\/about-hiv\/viral-load#item3116810 (2017)."},{"key":"92185_CR35","doi-asserted-by":"publisher","unstructured":"Meintjes, G. et al. Adult antiretroviral therapy guidelines 2017. South. Afr. J. HIV Med. 18 https:\/\/doi.org\/10.4102\/sajhivmed.v18i1.776 (2017).","DOI":"10.4102\/sajhivmed.v18i1.776"},{"key":"92185_CR36","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1097\/HJH.0b013e32830ef5fb","volume":"26","author":"M Baekken","year":"2008","unstructured":"Baekken, M., Os, I., Sandvik, L. & Oektedalen, O. Hypertension in an urban HIV-positive population compared with the general population: Influence of combination antiretroviral therapy. J. Hypertens. 26, 2126\u20132133 (2008).","journal-title":"J. Hypertens."},{"key":"92185_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2458-14-904","volume":"14","author":"GB Kagaruki","year":"2014","unstructured":"Kagaruki, G. B. et al. Magnitude and risk factors of non-communicable diseases among people living with HIV in Tanzania: A cross sectional study from Mbeya and Dar es Salaam regions. BMC Public Health 14, 1\u20139 (2014).","journal-title":"BMC Public Health"},{"key":"92185_CR38","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1097\/QAI.0000000000000267","volume":"67","author":"KV Narayan","year":"2014","unstructured":"Narayan, K. V. et al. HIV and noncommunicable disease comorbidities in the era of antiretroviral therapy: A vital agenda for research in low-and middle-income country settings. JAIDS J. Acquir. Immune Defic. Syndr. 67, S2\u2013S7 (2014).","journal-title":"JAIDS J. Acquir. Immune Defic. Syndr."},{"key":"92185_CR39","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1097\/QAD.0000000000001888","volume":"32","author":"P Patel","year":"2018","unstructured":"Patel, P. et al. Noncommunicable diseases among HIV-infected persons in low-income and middle-income countries: A systematic review and meta-analysis. AIDS 32, S5 (2018).","journal-title":"AIDS"},{"key":"92185_CR40","doi-asserted-by":"publisher","first-page":"e0122583","DOI":"10.1371\/journal.pone.0122583","volume":"10","author":"A Asfaw","year":"2015","unstructured":"Asfaw, A. et al. CD4 cell count trends after commencement of antiretroviral therapy among HIV-infected patients in Tigray, Northern Ethiopia: A retrospective cross-sectional study. PLoS ONE 10, e0122583 (2015).","journal-title":"PLoS ONE"},{"key":"92185_CR41","doi-asserted-by":"publisher","first-page":"18804","DOI":"10.7448\/IAS.17.1.18804","volume":"17","author":"S Kiertiburanakul","year":"2014","unstructured":"Kiertiburanakul, S. et al. Trends of CD4 cell count levels at the initiation of antiretroviral therapy over time and factors associated with late initiation of antiretroviral therapy among Asian HIV-positive patients. J. Int. AIDS Soc. 17, 18804 (2014).","journal-title":"J. Int. AIDS Soc."},{"key":"92185_CR42","doi-asserted-by":"publisher","first-page":"266","DOI":"10.4103\/0970-0218.103480","volume":"37","author":"ND Mrudula","year":"2012","unstructured":"Mrudula, N. D., Suwarna, U. P., Khadse, R., Minal, P. & Shubhangi, D. K. Statistical analysis and evaluation of CD4 count after 6 months on ART. Indian J. Community Med. 37, 266\u2013267. https:\/\/doi.org\/10.4103\/0970-0218.103480 (2012).","journal-title":"Indian J. Community Med."},{"key":"92185_CR43","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1590\/S0066-782X2010005000138","volume":"95","author":"ERD ArrudaJ\u00fanior","year":"2010","unstructured":"ArrudaJ\u00fanior, E. R. D. et al. Profile of patients with hypertension included in a cohort with HIV\/AIDS in the state of Pernambuco, Brazil. Arq. Bras. Cardiol. 95, 640\u2013647 (2010).","journal-title":"Arq. Bras. Cardiol."},{"key":"92185_CR44","doi-asserted-by":"publisher","first-page":"e0148100","DOI":"10.1371\/journal.pone.0148100","volume":"11","author":"CA Dimala","year":"2016","unstructured":"Dimala, C. A., Atashili, J., Mbuagbaw, J. C., Wilfred, A. & Monekosso, G. L. Prevalence of hypertension in HIV\/AIDS patients on highly active antiretroviral therapy (HAART) compared with HAART-na\u00efve patients at the Limbe Regional Hospital, Cameroon. PLoS ONE 11, e0148100 (2016).","journal-title":"PLoS ONE"},{"key":"92185_CR45","doi-asserted-by":"publisher","first-page":"89","DOI":"10.4103\/1947-2714.127751","volume":"6","author":"S Dua","year":"2014","unstructured":"Dua, S., Bhuker, M., Sharma, P., Dhall, M. & Kapoor, S. Body mass index relates to blood pressure among adults. N. Am. J. Med. Sci. 6, 89 (2014).","journal-title":"N. Am. J. Med. Sci."},{"key":"92185_CR46","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1111\/hiv.12259","volume":"16","author":"J Koethe","year":"2015","unstructured":"Koethe, J. et al. Body mass index and early CD4 T-cell recovery among adults initiating antiretroviral therapy in North America, 1998\u20132010. HIV Med. 16, 572\u2013577 (2015).","journal-title":"HIV Med."},{"key":"92185_CR47","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1089\/jwh.2012.3585","volume":"22","author":"M Maskew","year":"2013","unstructured":"Maskew, M. et al. Gender differences in mortality and CD4 count response among virally suppressed HIV-positive patients. J. Womens Health 22, 113\u2013120 (2013).","journal-title":"J. Womens Health"},{"key":"92185_CR48","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1097\/00002030-199912030-00007","volume":"13","author":"M Prins","year":"1999","unstructured":"Prins, M. et al. Do gender differences in CD4 cell counts matter?. AIDS 13, 2361\u20132364 (1999).","journal-title":"AIDS"},{"key":"92185_CR49","doi-asserted-by":"publisher","first-page":"361","DOI":"10.2147\/TCRM.S127765","volume":"13","author":"A Abossie","year":"2017","unstructured":"Abossie, A. & Yohanes, T. Assessment of isoniazid preventive therapy in the reduction of tuberculosis among ART patients in Arba Minch Hospital, Ethiopia. Ther. Clin. Risk Manag. 13, 361 (2017).","journal-title":"Ther. Clin. Risk Manag."},{"key":"92185_CR50","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12879-016-2109-7","volume":"17","author":"M Semu","year":"2017","unstructured":"Semu, M., Fenta, T. G., Medhin, G. & Assefa, D. Effectiveness of isoniazid preventative therapy in reducing incidence of active tuberculosis among people living with HIV\/AIDS in public health facilities of Addis Ababa, Ethiopia: A historical cohort study. BMC Infect. Dis. 17, 5 (2017).","journal-title":"BMC Infect. Dis."},{"key":"92185_CR51","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1089\/aid.2008.0173","volume":"25","author":"H Wang","year":"2009","unstructured":"Wang, H. et al. Consistent ART adherence is associated with improved quality of life, CD4 counts, and reduced hospital costs in central China. AIDS Res. Hum. Retroviruses 25, 757\u2013763 (2009).","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"92185_CR52","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1086\/339074","volume":"34","author":"S Mannheimer","year":"2002","unstructured":"Mannheimer, S., Friedland, G., Matts, J., Child, C. & Chesney, M. The consistency of adherence to antiretroviral therapy predicts biologic outcomes for human immunodeficiency virus-infected persons in clinical trials. Clin. Infect. Dis. 34, 1115\u20131121. https:\/\/doi.org\/10.1086\/339074 (2002).","journal-title":"Clin. Infect. Dis."},{"key":"92185_CR53","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1345\/aph.1Q546","volume":"46","author":"H Peyriere","year":"2012","unstructured":"Peyriere, H., Eiden, C., Macia, J.-C. & Reynes, J. Antihypertensive drugs in patients treated with antiretroviral. Ann. Pharmacother. 46, 703\u2013709 (2012).","journal-title":"Ann. Pharmacother."},{"key":"92185_CR54","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nri2471","volume":"9","author":"K Dorshkind","year":"2009","unstructured":"Dorshkind, K., Montecino-Rodriguez, E. & Signer, R. A. The ageing immune system: Is it ever too old to become young again?. Nat. Rev. Immunol. 9, 57\u201362 (2009).","journal-title":"Nat. Rev. Immunol."},{"key":"92185_CR55","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s10522-008-9138-6","volume":"9","author":"A Wikby","year":"2008","unstructured":"Wikby, A., M\u00e5nsson, I. A., Johansson, B., Strindhall, J. & Nilsson, S. E. The immune risk profile is associated with age and gender: Findings from three Swedish population studies of individuals 20\u2013100 years of age. Biogerontology 9, 299\u2013308 (2008).","journal-title":"Biogerontology"},{"key":"92185_CR56","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1111\/j.1468-1293.2012.01053.x","volume":"14","author":"S Wright","year":"2013","unstructured":"Wright, S. et al. Ageing and long-term CD 4 cell count trends in HIV-positive patients with 5 years or more combination antiretroviral therapy experience. HIV Med. 14, 208\u2013216 (2013).","journal-title":"HIV Med."},{"key":"92185_CR57","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1097\/QAD.0b013e328351f5b2","volume":"26","author":"O Ajose","year":"2012","unstructured":"Ajose, O., Mookerjee, S., Mills, E. J., Boulle, A. & Ford, N. Treatment outcomes of patients on second-line antiretroviral therapy in resource-limited settings: A systematic review and meta-analysis. AIDS 26, 929\u2013938 (2012).","journal-title":"AIDS"},{"key":"92185_CR58","unstructured":"World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach (World Health Organization, 2016)."},{"key":"92185_CR59","unstructured":"McLay, D. & Knowles, Z. HIV viral load testing: CATIE factsheet, https:\/\/www.catie.ca\/fact-sheets\/testing\/hiv-viral-load-testing (2017)."},{"key":"92185_CR60","unstructured":"HIV i-Base. Guide to changing ART: what to do if viral load rebounds, https:\/\/i-base.info\/guides\/wp-content\/uploads\/2017\/11\/Changing-ART-January-2018e.pdf (2018)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-92185-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-92185-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-92185-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T10:05:37Z","timestamp":1670061937000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-92185-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,21]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["92185"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-92185-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2021,6,21]]},"assertion":[{"value":"27 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12955"}}